首页> 外文期刊>The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation >Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement
【24h】

Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement

机译:中性粒细胞明胶酶相关的脂蛋白和半胱氨酸蛋白酶抑制剂C可预测晚期心力衰竭和心室辅助装置放置后的临床事件

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Progressive renal dysfunction develops in patients with advanced HF. We evaluated neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C compared with established markers of renal function in patients with heart failure (HF) because they might improve prognostic assessment of patients with HF.
机译:背景:晚期HF患者发展为进行性肾功能不全。我们将中性粒细胞明胶酶相关的脂蛋白(NGAL)和半胱氨酸蛋白酶抑制剂C与心力衰竭(HF)患者的肾功能标记物进行了比较,因为它们可能会改善心衰患者的预后评估。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号